Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
A second ALS lithium trial is ended after an interim analysis revealed no benefit and possible toxicity
Posted on Friday, November 6, 2009 - 13:25, By: ALSN Staff
An Italian trial to test the effects of lithium carbonate in amyotrophic lateral sclerosis (ALS) has ended before its originally scheduled completion date because of an unusually high number of dropouts, lack of demonstrated benefit, and concerns about the drug's possible toxicity.
Posted on Sunday, June 1, 2008 - 09:16, By: Other
MDA-funded lithium trial is now open